| 000 | 01462 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515020759.0 | ||
| 264 | 0 | _c20060911 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.2005.02576.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWyplosz, Benjamin | |
| 245 | 0 | 0 |
_aTolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cApr 2006 |
||
| 300 |
_a474 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aButanones _xadverse effects |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aDiclofenac _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKnee Joint |
| 650 | 0 | 4 | _aNabumetone |
| 650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 650 | 0 | 4 |
_aSulfonamides _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVautier, Sarah | |
| 700 | 1 | _aLillo-Le Louët, Agnès | |
| 700 | 1 | _aCapron, Loïc | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 61 _gno. 4 _gp. 474 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.2005.02576.x _zAvailable from publisher's website |
| 999 |
_c16150835 _d16150835 |
||